Skip to Main Content


Taylor Rogan

Postgraduate Associate

Contact Information

Taylor Rogan

Research Summary

First study: A double-blind RCT assessing Ketamine as a treatment for depression in individuals with Parkinson's Disease, secondary outcomes measuring decrease in tremor or motor symptoms.

Second Study: An Open-Label, Study of the Feasibility and the Usability of an App to Deliver Targeted Cognitive and Behavioral Exercises, in Addition to Treatment as Usual, to Patients Recently Hospitalized for Suicidal Ideation or Suicide Attempts

Third Study: Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention (ENDURE).

Research Interests

Feeding and Eating Disorders; Holistic Health; Personality Disorders; Psychopathology; Psychology, Developmental; Psychiatry and Psychology

Research Image